We have located links that may give you full text access.
E-Multidisciplinary Oncology Conference for Liver Cancer as a Technology and Method to Optimize Personalization and Outcomes in the Peripheries.
Studies in Health Technology and Informatics 2022 January 15
AIM: To search feasibility and reliability of Telemedicine Systems (TS) in the remote multidisciplinary oncology conference for decision making and treatment of liver lesions.
MATERIAL AND METHODS: By an experimental TS, twenty six (n=26) specialists based on a series of five (N=5) simulated remote image examinations, assessed sensitivity-specificity of the remote examination of the Liver (L) for neoplastic diseases and damages (Virtual Examination=VE).
RESULTS: Analysis showed injuries (sensitivity=96%), injuries of the capsula (sensitivity=91.7%), hematomas (sensitivity=91,7%), non-neoplastic diseases (specificity=100%), neoplastic diseases (sensitivity=100%).
CONCLUSION: The VE of the (L) in combination with high-tech visualization and multimedia and the remote participation of liver surgical oncology, oncology, radiology, pathology and cytology experts composes a feasible and reliable e-Multidisciplinary Oncologic Conference for a Personalized and Optimum Decision Making and Treatment in Liver Cancer.
MATERIAL AND METHODS: By an experimental TS, twenty six (n=26) specialists based on a series of five (N=5) simulated remote image examinations, assessed sensitivity-specificity of the remote examination of the Liver (L) for neoplastic diseases and damages (Virtual Examination=VE).
RESULTS: Analysis showed injuries (sensitivity=96%), injuries of the capsula (sensitivity=91.7%), hematomas (sensitivity=91,7%), non-neoplastic diseases (specificity=100%), neoplastic diseases (sensitivity=100%).
CONCLUSION: The VE of the (L) in combination with high-tech visualization and multimedia and the remote participation of liver surgical oncology, oncology, radiology, pathology and cytology experts composes a feasible and reliable e-Multidisciplinary Oncologic Conference for a Personalized and Optimum Decision Making and Treatment in Liver Cancer.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app